Abstract
Background
Primary duodenal cancer (PDC) is rare and few studies have addressed it adequately, especially in China. The present study is to evaluate the clinicopathological features and prognosis of PDC in Chinese patients.
Patients and methods
All the consecutive cases confirmed as PDC by histopathological analysis in The First Affiliated Hospital of Sun Yat-sen University between 1995 and 2008 were included. Clinicopathological details were retrospectively analysed and prognostic factors influencing survival were evaluated.
Results
The patient cohort included 53 men and 38 women, accounting for only 0.02% of all in-patients during this period. Esophagogastroduodenoscopy and gastrointestinal barium radiography were mainstay diagnostic tests for PDC; they detected 88.6% and 83.3% of the tumours, respectively. Tumours mainly occurred in the descending portion of the duodenum (67.0%). Abdominal pain was the most frequent symptom (56.0%). Histologically, adenocarcinoma was the most common type (74.7%). The overall 1-, 3- and 5-year survival rates were 62.6%, 43.7% and 33.1%, respectively. Patients survived longer in the curative surgery group (median survival time of 45 months) than those in the palliative group (6 months) (P < 0.001). Nodal metastasis and positive resection margin had a significant negative impact on survival in patients undergoing potentially curative surgery in a univariate and multivariate model (P < 0.05).
Conclusion
Patients with PDC are rare and lack specific presentations. Esophagogastroduodenoscopy and gastrointestinal barium radiography are effective in screening this rare tumour. Nodal metastasis and positive resection margins are associated with a poor prognosis. A curative surgery that achieves complete resection with negative margin should be pursued.
Similar content being viewed by others
References
Spira IA, Ghazi A, Wolff WI (1977) Primary adenocarcinoma of the duodenum. Cancer 39:1721–1726
Kerremans RP, Lerut J, Penninckx FM (1979) Primary malignant duodenal tumors. Ann Surg 190:179–182
Alwmark A, Andersson A, Lasson A (1980) Primary carcinoma of the duodenum. Ann Surg 191:13–18
Delacore R, Thomas JH, Forster J, Hermreck AS (1993) Improving resectability and survival in patients with primary duodenal carcinoma. Am J Surg 166:626–630
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
Greene FL, Compton CC, Fritz AG, Shah J, Winchester DP (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Kim SH, Roth KA, Moser AR, Gordon JI (1993) Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J Cell Biol 123:877–893
Kitchen PA, Walters JR (2001) Molecular and cellular biology of small-bowel mucosa. Curr Opin Gastroenterol 17:104–109
Lowenfels AB (1973) Why are small-bowel tumors so rare? Lancet 1:24–26
Arber N, Neugut AI, Weinstein IB, Holt P (1997) Molecular genetics of small bowel cancer. Cancer Epidemiol Biomark Prev 6:745–748
Bal A, Joshi K, Vaiphei K, Wig JD (2007) Primary duodenal neoplasms: a retrospective clinico-pathological analysis. World J Gastroenterol 13:1108–1111
Hung FC, Kuo CM, Chuah SK, Kuo CH, Chen YS, Lu SN, Chang Chien CS (2007) Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol 22:724–728
Sohn TA, Lillemoe KD, Cameron JL et al (1998) Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 2:79–87
Hurtuk MG, Devata S, Brown KM, Oshima K, Aranha GV, Pickleman J, Shoup M (2007) Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? Am J Surg 193:319–324
Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA (2000) Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg 135:1070–1074
Rotman N, Pezet D, Fagniez PL, Cherqui D, Celicout B, Lointier P (1994) Adenocarcinoma of the duodenum: factors influencing survival. Br J Surg 81:83–85
Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH (2009) The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer 40:33–37
Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W (2006) Surgical treatment of primary duodenal adenocarcinoma. Hepatogastroenterology 53:858–862
Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F (1997) Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology 44:1157–1163
Heniford BT, Iannitti DA, Evans P, Gaqner M, Henderson JM (1998) Primary nonampullary/periampullary adenocarcinoma of the duodenum. Am Surg 64:1165–1169
Barnes G Jr, Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78
Bakaeen FG, Murr MM, Sarr MG et al (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135:635–641
Solej M, D’Amico S, Brondino G, Ferronato M, Nano M (2008) Primary duodenal adenocarcinoma. Tumori 94:779–786
Freeman AH (2001) CT and bowel disease. Br J Radiol 74:4–14
Kazerooni EA, Quint LE, Francis IR (1992) Duodenal neoplasms: predictive value of CT for determining malignancy and tumor resectability. AJR Am J Roentgenol 159:303–309
Adedeji OA, Trescoli-Serrano C, Garcia-Zarco M (1995) Primary duodenal carcinoma. Postgrad Med J 71:354–358
Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW (2008) Prognostic factors for primary duodenal adenocarcinoma. World J Surg 32:2246–2252
Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N (1998) The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomark Prev 7:243–251
Ross RK, Hartnett NM, Bernstein L, Henderson BE (1991) Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer 63:143–145
Rose DM, Hochwald SN, Klimstra DS, Brennan MF (1996) Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 183:89–96
Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS (2000) Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 179:37–41
Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC (2004) Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol 11:380–386
Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR (2009) Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol 100:144–148
Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ (2007) Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. Ann Surg Oncol 14:3159–3167
Acknowledgements
The authors greatly thank Dr Brandon Steelman from Stanford University, Tracy Zhu from Chinese University of Hong Kong and Mr Steven Lee from Indiana University–Purdue University Indianapolis for their kind critical reading and linguistic revisions of the manuscript. We thank Dr Zijin Weng and Prof. Yu Tao from Division of Pathology of Sun Yat-sen University for helpful suggestions on the pathological typing and skilful technical assistance. We also thank Prof. Yuantao Hao from Department of Statistics and Epidemiology, Sun Yat-sen University for his kind help on statistics. In addition, we appreciate all the doctors and students for their great work in building the gastrointestinal tumour database.
Conflicts of interest
None.
Funding source
This study is sponsored by Science and Technology Foundation of Guangdong Province (no. 2008B030301298, 2009B030801174), Yat-sen innovative talents’ training program of outstanding supervisor of Sun Yat-sen University and International Program Fund of 985 Project of Sun Yat-sen University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presentation of meeting: The abstract of this article was accepted as poster presentation by the meeting of GASTRO 2009, UEGW/WCOG in London.
Shenghong Zhang and Yi Cui have contributed equally to the work.
Rights and permissions
About this article
Cite this article
Zhang, S., Cui, Y., Zhong, B. et al. Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China. Int J Colorectal Dis 26, 219–226 (2011). https://doi.org/10.1007/s00384-010-1063-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-010-1063-x